BiomX Inc. will release its second quarter 2025 financial results and program updates on August 13, 2025, before the U.S. financial markets open. A conference call and webcast will follow at 8 a.m. ET. To participate, register five minutes before the call or listen via the webcast. Dial-in and webcast details available on the company’s website.

BiomX is a clinical-stage company developing natural and engineered phage therapies to target specific pathogenic bacteria for chronic diseases. The company utilizes its BOLT platform to customize phage compositions against proprietary bacterial targets. For more information, visit BiomX’s website. Contact Ben Cohen at [email protected] for further inquiries.

Read more at GlobeNewswire: BiomX to Report Second Quarter 2025 Financial Results and